Power Law company profile

Cerevel Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.87B

Market cap · 2026

Investors

1 investor on Cerevel Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Bain Capital

Global footprint

Where Cerevel Therapeutics has talent and traffic

Web traffic by country

530 monthly visits
across markets

🇮🇱 Israel94.3%

Top 1 markets shown

Patent intelligence

$82k patent portfolio · 3 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$82k

<0.01% of market cap · 212.4× smaller than top peer Sinovent ($17M)

3 active patent families

Where Cerevel Therapeutics innovates Pharmaceutical SubstancesMedicinal chemistryAzepindolePhosphodiesterase inhibitorPharmaceutical drug

Above peer median on Strategic · Below peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

Cerevel Therapeutics on the five Patsnap quality dimensions

Cerevel Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Cerevel Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Cerevel Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Cerevel Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo